Glenmede Trust CO Na Vanda Pharmaceuticals Inc. Transaction History

Glenmede Trust CO Na

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$9.77 - $13.81 $14,498 - $20,494	-1,484 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$9.66 - $12.02 $2,395 - $2,980	248 Added 20.06%	1,484 $16,000
Q4 2019 Feb 12, 2020	BUY	$12.38 - $17.47 $2,092 - $2,952	169 Added 15.84%	1,236 $20,000
Q3 2019 Nov 14, 2019	SELL	$12.27 - $15.79 $5.22 Million - $6.72 Million	-425,659 Reduced 99.75%	1,067 $13,000
Q2 2019 Aug 13, 2019	SELL	$13.37 - $18.85 $18.5 Million - $26 Million	-1,381,475 Reduced 76.4%	426,726 $6.01 Million
Q1 2019 May 14, 2019	BUY	$17.59 - $31.05 $9.41 Million - $16.6 Million	534,990 Added 42.02%	1,808,201 $33.3 Million
Q4 2018 Feb 14, 2019	SELL	$18.97 - $31.47 $9.36 Million - $15.5 Million	-493,535 Reduced 27.93%	1,273,211 $33.3 Million
Q3 2018 Nov 15, 2018	BUY	$18.25 - $23.0 $32.2 Million - $40.6 Million	1,766,208 Added 328291.44%	1,766,746 $40.5 Million
Q2 2018 Aug 15, 2018	SELL	$13.95 - $19.15 $502 - $689	-36 Reduced 6.27%	538 $10,000
Q4 2017 Feb 15, 2018	BUY	$12.85 - $18.1 $7,375 - $10,389	574	574 $8,000

153

43.3M

33.8K

28.7K

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $247M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

Get notified when there are updates to the investment portfolio of Glenmede Trust CO Na, based on Form 13F filings with the SEC.

Stay updated on Glenmede Trust CO Na with notifications on news.